Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease
Ritu Pasrija, Mohammad Naime
International Immunopharmacology (2020) Vol. 90, pp. 107225-107225
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm
Ali A. Rabaan, Shamsah H. Al-Ahmed, Javed Muhammad, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 436-436
Open Access | Times Cited: 224
The Role of Th17 Response in COVID-19
Diana Martonik, Anna Parfieniuk‐Kowerda, Magdalena Rogalska, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1550-1550
Open Access | Times Cited: 117
SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”
Benjamín L. Sievers, Mark T. K. Cheng, Kata Csiba, et al.
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 171-183
Open Access | Times Cited: 51
COVID-19 and Bone Loss: A Review of Risk Factors, Mechanisms, and Future Directions
Amy Creecy, Olatundun D. Awosanya, Alexander Harris, et al.
Current Osteoporosis Reports (2024) Vol. 22, Iss. 1, pp. 122-134
Open Access | Times Cited: 20
SARS-CoV-2 and its Multifaceted Impact on Bone Health: Mechanisms and Clinical Evidence
Alexander Harris, Amy Creecy, Olatundun D. Awosanya, et al.
Current Osteoporosis Reports (2024) Vol. 22, Iss. 1, pp. 135-145
Open Access | Times Cited: 17
Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
Jialing Yin, Chengcheng Li, Chunhong Ye, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 824-837
Open Access | Times Cited: 65
Post-COVID-19 Condition: Where Are We Now?
Paula Boaventura, Sofia Macedo, Filipa M. Ribeiro, et al.
Life (2022) Vol. 12, Iss. 4, pp. 517-517
Open Access | Times Cited: 45
Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2
Elena Mitsi, Jesús Reiné, Britta C. Urban, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 7
Open Access | Times Cited: 43
The crucial regulatory role of type I interferon in inflammatory diseases
Ling Ji, Tianle Li, Huimin Chen, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 32
IL-6 and IL-10 are associated with disease severity and higher comorbidity in adults with COVID-19
Rafael Luís Luporini, Joice Margareth de Almeida Rodolpho, Lauro T. Kubota, et al.
Cytokine (2021) Vol. 143, pp. 155507-155507
Open Access | Times Cited: 49
An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution
Francisco Javier Gil‐Etayo, Sara Garcinuño, Alberto Utrero‐Rico, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 296-296
Open Access | Times Cited: 35
Alveolar macrophages: Achilles’ heel of SARS-CoV-2 infection
Zhenfeng Wang, Shunshun Li, Bo Huang
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 34
The role of SARS-CoV-2-mediated NF-κB activation in COVID-19 patients
Qiaoqiao Zhou, Lei Zhang, Yanming Dong, et al.
Hypertension Research (2023) Vol. 47, Iss. 2, pp. 375-384
Open Access | Times Cited: 21
Role of OAS gene family in COVID-19 induced heart failure
Lijuan Gao, Zhong‐Mei He, Yiying Li, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era
Ganggang Miao, Zhiqiang Chen, Hengsong Cao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114208-114208
Open Access | Times Cited: 17
Multi-cohort study on cytokine and chemokine profiles in the progression of COVID-19
Chaolin Huang, Xujuan Hu, Delong Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Interleukin-17A (IL-17A): A silent amplifier of COVID-19
Francesco Μaione, Gian Marco Casillo, Federica Raucci, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 111980-111980
Open Access | Times Cited: 41
Structural Analysis of SARS-CoV-2 ORF8 Protein: Pathogenic and Therapeutic Implications
Antonio Valcarcel, Antonio Bensussen, Elena Álvarez‐Buylla, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 36
Resolving the equation between mucormycosis and COVID-19 disease
Ritu Pasrija, Mohammad Naime
Molecular Biology Reports (2022) Vol. 49, Iss. 4, pp. 3349-3356
Open Access | Times Cited: 23
Analysis of Plasma Proteins Involved in Inflammation, Immune Response/Complement System, and Blood Coagulation upon Admission of COVID-19 Patients to Hospital May Help to Predict the Prognosis of the Disease
Daniele Castro di Flora, Aline Dionízio, Heloísa Aparecida Barbosa Silva Pereira, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1601-1601
Open Access | Times Cited: 16
Role of the MicroRNAs in the Pathogenic Mechanism of Painful Symptoms in Long COVID: Systematic Review
Samuel Reyes-Long, José Luis Cortes-Altamirano, Cindy Bandala, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3574-3574
Open Access | Times Cited: 14
Integrating network pharmacology, experimental validation and molecular docking to reveal the alleviation of Yinhuang granule on idiopathic pulmonary fibrosis
Zeqi Wu, Ruijia Shi, Shihao Yan, et al.
Phytomedicine (2024) Vol. 128, pp. 155368-155368
Closed Access | Times Cited: 6
COVID-19: Not a thrombotic disease but a thromboinflammatory disease
Shu He, Margareta Blombäck, Håkan Wallén
Upsala Journal of Medical Sciences (2024) Vol. 129
Open Access | Times Cited: 6
Continuous Renal Replacement Therapy With oXiris Filter May Not be an Effective Resolution to Alleviate Cytokine Release Syndrome in Non-AKI Patients With Severe and Critical COVID-19
Kai Kang, Yunpeng Luo, Yang Gao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
Immune responses in COVID-19 patients: Insights into cytokine storms and adaptive immunity kinetics
J Zhang
Heliyon (2024) Vol. 10, Iss. 14, pp. e34577-e34577
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top